ATIVA’s rapid low-cost COVID-19 test may provide earlier detection and a safer community. The greatest challenge we face is the spread of infection before symptoms appear. We all want to protect our loved ones, so how do we know if we are carrying the virus? Physical symptoms (fever, cough) appear too late to stop the spread. The nasal swab PCR tests suffer from sampling errors, slow time to results, and are expensive. Early detection of infected people is the key to protecting our most vulnerable people...
In today’s world, access to essential services, even ones as simple and critical as a blood test, can be a struggle.
It is estimated that there are nearly 137 Million Emergency Room Visits per year in the United States alone.
In the Primary Care segment, blood and urine tests drive nearly 70% of Physician decisions, guiding nearly two-thirds of healthcare costs.